# Induction of Mixed Hemopoietic Chimerism in Patients Using Fludarabine, Low Dose TBI, PBSC Infusion and Post Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil

> **NCT00531635** · PHASE1 · UNKNOWN · sponsor: **King Faisal Specialist Hospital & Research Center** · enrollment: 350 (estimated)

## Conditions studied

- Post Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil

## Interventions

- **DRUG:** Mycophenolate Mofetil

## Key facts

- **NCT ID:** NCT00531635
- **Lead sponsor:** King Faisal Specialist Hospital & Research Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-07
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2011-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00531635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00531635, "Induction of Mixed Hemopoietic Chimerism in Patients Using Fludarabine, Low Dose TBI, PBSC Infusion and Post Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00531635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*